资讯

The Manila Times15 小时

Greenwich LifeSciences’ GLSI-100 Granted US FDA Fast Track Designation

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the 'Company'), a clinical-stage biopharmaceutical company focused on its Phase ...

Greenwich LifeSciences, Inc.: Greenwich LifeSciences' GLSI-100 Granted US FDA Fast Track ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...